Popular diabetes medications may protect against Alzheimer’s disease, UF researchers find
Dr. Serena Jingchuan Guo is the senior author of a study published in JAMA Neurology April 7.
All Posts by
Tyler Francischine
UF researchers demonstrate GLP-1RAs’ potential to treat depression
A study led by Dr. Serena Jingchuan Guo may carry significant implications for older patients with diabetes.
Students demonstrate innovation and collaboration at 38th Annual Research Showcase
The Feb. 17 event saw 112 poster presentations and 12 oral presentations from UF pharmacy students and trainees.
Graduate student Asinamai Ndai named Quality Improvement Champion by American Society of Hematology
Ndai received the award at the ASH annual meeting in San Diego, Dec. 7-10, 2024.
UF Health researchers receive NIH R01 grant to develop social risk management tool for people living with dementia
A team of UF Health researchers led by Serena Jingchuan Guo, M.D. Ph.D., aims to reduce health inequities faced by people living with dementia.
Interdisciplinary team led by Dr. Rachel Reise wins UF Health Shands Board Quasi Endowment award
Reise's team aims to improve the quality of ambulatory preoperative internal medicine consultation and perioperative medication reconciliation at UF Health Shands hospitals.
Dr. Haesuk Park wins UF Health Shands Board Quasi Endowment to study barriers to PrEP care
Park is conducting a survey study of UF Health providers about barriers to PrEP care in UF Health outpatient clinics.
Popular glucose-lowering drugs not linked to suicide risk in older adults, UF Health study finds
Serena Jingchuan Guo, M.D., Ph.D., spearheaded a study utilizing Medicare data from 21,000 older adults.
Dr. Serena Jingchuan Guo wins the UF Excellence Award for Assistant Professors
Serena Jingchuan Guo, an assistant professor in the UF College of Pharmacy department of pharmaceutical outcomes and policy, is a recipient of this year’s UF Excellence Award for Assistant Professors.
UF study uses machine learning to predict opioid use disorder treatment interruptions
University of Florida researchers have developed a system designed to identify patients at high risk of discontinuing buprenorphine treatment for opioid use disorder.
